Search

Search Results
Results 181 - 190 of 511 for breast cancer
  • Lenalidomide Viatris
    Drug - 24 Apr 2024
    Consumer Medicine Information (CMI) about Lenalidomide Viatris intended for persons living in Australia.
  • Piax Plus Asprin
    Drug - 3 Apr 2024
    Consumer Medicine Information (CMI) about Piax Plus Asprin (clopidogrel hydrogen sulfate and aspirin) intended for persons living in Australia.
  • DBL Cytarabine
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Cytarabine (Cytarabine) intended for persons living in Australia.
  • Salpraz Heartburn Relief (reformulation 2)
    Drug - 5 Jan 2023
    Consumer Medicine Information (CMI) about Salpraz Heartburn Relief (reformulation 2) (Pantoprazole enteric coated tablets) intended for persons living in Australia.
  • Somac Heartburn Relief
    Drug - 17 Aug 2022
    Consumer Medicine Information (CMI) about Somac Heartburn Relief (pantoprazole sodium sesquihydrate) intended for persons living in Australia.
  • Moxicam Tablets
    Drug - 18 Jan 2022
    Consumer Medicine Information (CMI) about Moxicam Tablets (meloxicam) intended for persons living in Australia.
  • Maxor EC
    Drug - 30 Aug 2021
    Consumer Medicine Information (CMI) about Maxor EC (omeprazole) intended for persons living in Australia.
  • Valcyte Tablets
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Tablets (valganciclovir) intended for persons living in Australia.
  • Minidiab
    Drug - 17 Apr 2025
    Consumer Medicine Information (CMI) about Minidiab intended for persons living in Australia.
  • Noxicid Caps Heartburn Relief
    Drug - 16 Apr 2025
    Consumer Medicine Information (CMI) about Noxicid Caps Heartburn Relief intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback